Trial intelligence / Profile preview

Adhesion and PK of ZTlido in Healthy Adults Under Water Stress

NCT04784728Phase 1Completed

Sponsor
Scilex Holding
Start
Aug 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of lidocaine topical system in postherpetic neuralgia (PHN) (3 arms), sponsored by Scilex Holding. Primary endpoint: Mean cumulative adhesion score at 12 hours. Started Aug 2019; status: completed.

02

Drugs

lidocaine topical system
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT04784728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04784728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call